Antimicrobial Drug Development Studies
C-CAMP in collaboration with IHMA, a premier provider of antimicrobial drug development studies, offers a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization. With facilities in the USA, Europe, China and India, IHMA is able to collaborate with and support companies around the world in the pharmaceutical, biotechnology and diagnostic device industry.
We partner with companies requiring:
Pre-clinical studies including in vitro studies (antibacterial and antifungal)
- MIC Profiling
- Time Kill
- Resistance Development
- Drug Interactions
- Post-antibiotic Effect
Global support of all phases of clinical trials
- Therapeutics
- Diagnostic Devices
Antimicrobial resistance (AMR) surveillance
- Bacterial
- Fungal
Molecular Characterization of AMR
- WGS diagnostics
Support with New Therapeutic Approaches
- Bacteriophage
To request a service, contact services[at]ccamp.res.in | www.ihma.com | www.ccamp.res.in/ds